ArticleMedicine2026
Neuro-ophthalmic observation and 16-month follow-up of horner syndrome after thyroidectomy: A case report.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleHorner syndrome (HS) is a rare but underrecognized complication of thyroidectomy, typically resulting from intraoperative injury to the cervical sympathetic chain. Its clinical manifestations include ptosis, miosis, enophthalmos, anhidrosis, and vasodilation. However, data on causative factors, progression of ocular signs, and clinical recovery timing remain limited. This study aimed to clarify these aspects to establish reference intervals for patient management. PATIENT CONCERNS: A 29-year-old female developed postoperative miosis and ptosis following endoscopic thyroidectomy. Her primary concern was persistent ocular symptoms affecting daily life. DIAGNOSES: HS was confirmed through comprehensive evaluation, including ptosis measurement, scotopic pupillometry, and positive response to 0.2% brimonidine testing.
interventionsShe received intravenous methylprednisolone (80 mg/day for 10 days) and oral methylcobalamin (0.5 mg 3 times daily for 30 days). OUTCOMES: At 16-month follow-up, partial persistence of miosis and ptosis was observed; however, facial sweating normalized, and other ocular symptoms resolved completely. LESSONS: HS should be considered a potential complication of thyroidectomy, even when rare. Simple clinical and pharmacologic tests (e.g., brimonidine test) suffice for confirmation. Notably, complete recovery from iatrogenic HS secondary to endoscopic thyroidectomy may exceed 12 months, highlighting the need for long-term follow-up and patient counseling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.